Table 3.
Laboratory data.
| Type of presentation | KDSS in this study (n = 6) | KDSS worldwide (19) (n = 106) |
MIS-C in Italy (5) (n = 10) |
MIS-C in UK (6) (n = 58) |
MIS-C in NewYork (7) (n = 99) |
MIS-C in US (8) (n = 186) |
|---|---|---|---|---|---|---|
| CRP (mg/dL) | 20.1 (12.0, 25.8) | 19.1* | 24.1 (9.7, 27.9) | 22.9 (156, 338) | 21.9 (15.0, 30.0) | 17.8 (12.8, 25.9) |
| ESR (/mm) | 115 (93, 122) | 61.9* | 75.5 (51, 97) | ND | 61.5 (43.0, 77.5) | 65 (42, 91) |
| White blood cell count (× 103/mm3) | 13.6 (12.8, 19.3) | 17.3* | 10.8 (6.1)* | 17 (12, 22) | 10.4 (6.7, 14.5) | ND |
| Neutrophils (%) | 87.5% (85.3, 91.3) | 81.0* | 84.8% (78.6, 90.3) | 13 (10, 19) | 82.0% (76.0–89.0) | ND |
| Lymphocytes (× 103/mm3) | 1.44 (1.04, 1.72) | ND | 0.83 (0.46, 1.12) | 0.80 (0.50, 1.50) | ND | ND |
| 9.0% (5.7, 11.4) | 10.0% (5.0, 16.0) | |||||
| Hemoglobin (g/dL) | 10.6 (9.2, 12.6) | 11.1* | 11 (1.2)* | 9.2 (8.3, 10.3) | ND | <9.0: 48% |
| Platelets (× 104/mm3) | 24.1 (21.4, 26.6) | ND | 13.0 (11.6, 14.2) | 15.1 (10.4, 21.0) | 15.5 (10.5, 23.3) | 13.3 (8.8, 23.5) |
| ALT (IU/L) | 41.5 (25, 77) | 97.1* | 56 (26, 79) | 42 (26, 95) | ND | ND |
| Albumin (g/dL) | 2.4 (2.0, 2.8) | 2.4* | 3.2 (0.3)* | 2.4 (2.1, 2.7) | 3.1 (2.5, 3.6) | 2.5 (2.0, 2.9) |
| Ferritin (ng/mL) | 548 (447, 646) | ND | 893 (324, 2000) | 610 (359, 1280) | ND | 639 (332.7, 1178.2) |
| CPK (U/L) | 29 (22, 52) | ND | 78 (40, 87) | ND | ND | ND |
| Elevated BNP or NT-pro BNP (%) | 100% | ND | 100% | ND | 90% | ND |
Median (IQR).
*
Mean. ND, No data.